Andrews Nancy C

SEC Form 4 insider trading activity

Andrews Nancy C has filed 3 SEC Form 4 filings (5 transaction rows) across 1 company, with disclosures dating back to 2026. 3 of those filings fall inside the rolling window. Most recent filing: Aug 20, 2026.

On the most recent filing, Andrews Nancy C is listed as Director at CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Inside the rolling window, Andrews Nancy C reported no open-market purchases and 1 open-market sale totaling $163K in CRL.

Companies traded

Other insiders at CRL

Insider Buying

$0

reported purchases (SEC code P)

Insider Selling

$163K

reported sales (SEC code S)

Companies

1

in the rolling window

Source
CRL
Andrews Nancy C
Sale$163KAug 20SEC ↗
Showing 1–1 of 1
1 / 1

Frequently asked questions

How many SEC Form 4 filings has Andrews Nancy C made?

Andrews Nancy C has filed 3 SEC Form 4 filings (5 transaction rows) across 1 company since 2026.

Which companies does Andrews Nancy C trade?

Andrews Nancy C has filed SEC Form 4 disclosures for 1 company, including CRL.

When was Andrews Nancy C's most recent SEC Form 4 filing?

Andrews Nancy C's most recent SEC Form 4 filing on Tracefour is dated Aug 20, 2026.

What is Andrews Nancy C's total buy and sell value in the current window?

Inside the rolling retention window, Andrews Nancy C bought $0 and sold $163K based on SEC Form 4 filings.

What was Andrews Nancy C's largest disclosed transaction?

The largest disclosed transaction in the current window is a sale of 573 CRL shares on 2026-08-18, worth $163K, per SEC Form 4 filings.